Invezz is an independent platform with the goal of helping users achieve financial freedom. In order to fund our work, we partner with advertisers who compensate us for users that Invezz refers to their services. While our reviews and assessments of each product on the site are independent and unbiased, brands may pay to appear higher up our table rankings or place ads in specific areas of the site. The order in which products and services appear on Invezz does not represent an endorsement from us, and please be aware that there may be other platforms available to you than the products and services that appear on our website. Read more about how we make money >
GlaxoSmithKline plc (LON:GSK)
|Dividend Rate (ttm)||0.7833|
|Trading Day||Sep 17|
|Day's Range||13.882 - 14.882|
|52 Week Range||11.6 - 15.26|
GlaxoSmithKline plc dividends
Glaxosmithkline plc has a market cap or net worth of £69.85 billion. The enterprise value is £0.
Glaxosmithkline plc has 5.03 billion shares outstanding.
The trailing PE ratio is 0.0000 and the forward PE ratio is 0.0000. Glaxosmithkline plc's PEG ratio is 0.0000.
Stock Price Statistics
The stock price has increased by 0.0817%. The beta is 0.0000, so Glaxosmithkline plc's price volatility has been lower than the market average.
In the last 12 months, Glaxosmithkline plc had revenue of £0 and earned £0 in profits. Earnings per share was £.
980 Great West Road
GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer..